BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 10656987)

  • 21. Activation of Akt/protein kinase B overcomes a G(2)/m cell cycle checkpoint induced by DNA damage.
    Kandel ES; Skeen J; Majewski N; Di Cristofano A; Pandolfi PP; Feliciano CS; Gartel A; Hay N
    Mol Cell Biol; 2002 Nov; 22(22):7831-41. PubMed ID: 12391152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Shc and FAK differentially regulate cell motility and directionality modulated by PTEN.
    Gu J; Tamura M; Pankov R; Danen EH; Takino T; Matsumoto K; Yamada KM
    J Cell Biol; 1999 Jul; 146(2):389-403. PubMed ID: 10427092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic alterations and aberrant expression of genes related to the phosphatidyl-inositol-3'-kinase/protein kinase B (Akt) signal transduction pathway in glioblastomas.
    Knobbe CB; Reifenberger G
    Brain Pathol; 2003 Oct; 13(4):507-18. PubMed ID: 14655756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pten, a protean tumor suppressor.
    Mutter GL
    Am J Pathol; 2001 Jun; 158(6):1895-8. PubMed ID: 11395362
    [No Abstract]   [Full Text] [Related]  

  • 25. Involvement of neutral endopeptidase in neoplastic progression.
    Sumitomo M; Shen R; Nanus DM
    Biochim Biophys Acta; 2005 Aug; 1751(1):52-9. PubMed ID: 16054017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells.
    St-Germain ME; Gagnon V; Mathieu I; Parent S; Asselin E
    Int J Oncol; 2004 May; 24(5):1311-24. PubMed ID: 15067356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The tumor suppressor PTEN regulates T cell survival and antigen receptor signaling by acting as a phosphatidylinositol 3-phosphatase.
    Wang X; Gjörloff-Wingren A; Saxena M; Pathan N; Reed JC; Mustelin T
    J Immunol; 2000 Feb; 164(4):1934-9. PubMed ID: 10657643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma.
    Hu X; Pandolfi PP; Li Y; Koutcher JA; Rosenblum M; Holland EC
    Neoplasia; 2005 Apr; 7(4):356-68. PubMed ID: 15967113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DJ-1, a novel regulator of the tumor suppressor PTEN.
    Kim RH; Peters M; Jang Y; Shi W; Pintilie M; Fletcher GC; DeLuca C; Liepa J; Zhou L; Snow B; Binari RC; Manoukian AS; Bray MR; Liu FF; Tsao MS; Mak TW
    Cancer Cell; 2005 Mar; 7(3):263-73. PubMed ID: 15766664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
    Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W
    Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PKB/Akt mediates radiosensitization by the signaling inhibitor LY294002 in human malignant gliomas.
    Nakamura JL; Karlsson A; Arvold ND; Gottschalk AR; Pieper RO; Stokoe D; Haas-Kogan DA
    J Neurooncol; 2005 Feb; 71(3):215-22. PubMed ID: 15735908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PTEN augments staurosporine-induced apoptosis in PTEN-null Ishikawa cells by downregulating PI3K/Akt signaling pathway.
    Wan X; Yokoyama Y; Shinohara A; Takahashi Y; Tamaya T
    Cell Death Differ; 2002 Apr; 9(4):414-20. PubMed ID: 11965494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway.
    Sun H; Lesche R; Li DM; Liliental J; Zhang H; Gao J; Gavrilova N; Mueller B; Liu X; Wu H
    Proc Natl Acad Sci U S A; 1999 May; 96(11):6199-204. PubMed ID: 10339565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death.
    Weng LP; Smith WM; Dahia PL; Ziebold U; Gil E; Lees JA; Eng C
    Cancer Res; 1999 Nov; 59(22):5808-14. PubMed ID: 10582703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pten signaling in gliomas.
    Knobbe CB; Merlo A; Reifenberger G
    Neuro Oncol; 2002 Jul; 4(3):196-211. PubMed ID: 12084351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphoinositide signaling in urological disease.
    Theodorescu D
    J Urol; 2003 Jun; 169(6):2394-6. PubMed ID: 12771804
    [No Abstract]   [Full Text] [Related]  

  • 37. Indole-3-carbinol inhibits protein kinase B/Akt and induces apoptosis in the human breast tumor cell line MDA MB468 but not in the nontumorigenic HBL100 line.
    Howells LM; Gallacher-Horley B; Houghton CE; Manson MM; Hudson EA
    Mol Cancer Ther; 2002 Nov; 1(13):1161-72. PubMed ID: 12479697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural assets of a tumor suppressor.
    Tonks NK; Myers MP
    Science; 1999 Dec; 286(5447):2096-7. PubMed ID: 10617421
    [No Abstract]   [Full Text] [Related]  

  • 39. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway.
    Manning BD; Tee AR; Logsdon MN; Blenis J; Cantley LC
    Mol Cell; 2002 Jul; 10(1):151-62. PubMed ID: 12150915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of PTEN and Akt in the regulation of growth and apoptosis in human osteoblastic cells.
    Nielsen-Preiss SM; Silva SR; Gillette JM
    J Cell Biochem; 2003 Dec; 90(5):964-75. PubMed ID: 14624456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.